Protective effect of S-allyl cysteine sulphoxide (alliin) on glycoproteins and hematology in isoproterenol induced myocardial infarction in male Wistar rats
- PMID: 18172887
- DOI: 10.1002/jat.1330
Protective effect of S-allyl cysteine sulphoxide (alliin) on glycoproteins and hematology in isoproterenol induced myocardial infarction in male Wistar rats
Abstract
The antihyperlipidemic, antilipoperoxidative and antioxidant effects of S-allyl cysteine sulphoxide (SACS) in myocardial infarcted rats were reported previously. The present study was undertaken to evaluate the preventive role of SACS on some biochemical parameters, glycoproteins and hematology in experimentally induced myocardial infarction in rats. Myocardial infarction was induced in rats by subcutaneous injection of isoproterenol (ISO) (150 mg kg(-1)) at an interval of 24 h for 2 days. ISO-treated rats showed a significant increase in the levels of serum iron, uric acid and blood glucose, Na(+) and Ca(2+) in the heart and a significant decrease in the levels of plasma iron binding capacity, serum total protein, albumin/globulin ratio, heart K(+) and heart glycogen. The levels/concentrations of glycoproteins in serum and the heart were increased in myocardial infarcted rats. Myocardial infarcted rats also showed a significant increase in red blood cells, hemoglobin, packed cell volume, white blood cells, neutrophils, platelet count and fibrinogen level and a significant decrease in erythrocyte sedimentation rate, eosinophils, lymphocytes, bleeding, clotting and prothrombin time. Oral pretreatment with SACS (40 and 80 mg kg(-1)) daily for a period of 35 days showed a positive effect on all the biochemical parameters studied in ISO-induced rats. Thus, the study showed the protective effect of SACS on ISO-induced cardiotoxicity in male Wistar rats.
2008 John Wiley & Sons, Ltd
Similar articles
-
Preventive effect of S-allylcysteine on membrane-bound enzymes and glycoproteins in normal and isoproterenol-induced cardiac toxicity in male Wistar rats.Basic Clin Pharmacol Toxicol. 2008 Dec;103(6):507-13. doi: 10.1111/j.1742-7843.2008.00244.x. Basic Clin Pharmacol Toxicol. 2008. PMID: 19067678
-
Preventive effect of S-allyl cysteine sulfoxide (alliin) on lysosomal hydrolases and membrane-bound ATPases in isoproterenol-induced myocardial infarction in Wistar rats.J Biochem Mol Toxicol. 2007;21(3):118-24. doi: 10.1002/jbt.20166. J Biochem Mol Toxicol. 2007. PMID: 17623887
-
Preventive effect of S-allyl cysteine sulfoxide (alliin) on cardiac marker enzymes and lipids in isoproterenol-induced myocardial injury.J Pharm Pharmacol. 2006 May;58(5):617-23. doi: 10.1211/jpp.58.5.0006. J Pharm Pharmacol. 2006. PMID: 16640830
-
Antilipoperoxidative and antioxidant effects of S-allyl cysteine sulfoxide on isoproterenol-induced myocardial infarction in Wistar rats.J Biochem Mol Toxicol. 2006;20(4):167-73. doi: 10.1002/jbt.20132. J Biochem Mol Toxicol. 2006. PMID: 16906521
-
Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats.Chem Biol Interact. 2009 May 15;179(2-3):118-24. doi: 10.1016/j.cbi.2008.12.012. Epub 2008 Dec 25. Chem Biol Interact. 2009. PMID: 19146839
Cited by
-
Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Energy Homeostasis of Dairy Animals: Exploiting Their Modulation through Nutrigenomic Interventions.Int J Mol Sci. 2021 Nov 18;22(22):12463. doi: 10.3390/ijms222212463. Int J Mol Sci. 2021. PMID: 34830341 Free PMC article. Review.
-
Fortified S-Allyl L-Cysteine: Animal Safety, Effect on Retinal Ischemia, and Role of Wnt in the Underlying Therapeutic Mechanism.Evid Based Complement Alternat Med. 2020 Oct 3;2020:3025946. doi: 10.1155/2020/3025946. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33082821 Free PMC article.
-
Modulatory Effect of Guinep (Melicoccus bijugatus Jacq) Fruit Pulp Extract on Isoproterenol-Induced Myocardial Damage in Rats. Identification of Major Metabolites Using High Resolution UHPLC Q-Orbitrap Mass Spectrometry.Molecules. 2019 Jan 10;24(2):235. doi: 10.3390/molecules24020235. Molecules. 2019. PMID: 30634603 Free PMC article.
-
Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases.PPAR Res. 2012;2012:318613. doi: 10.1155/2012/318613. Epub 2012 Nov 28. PPAR Res. 2012. PMID: 23251142 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous